Client
A biopharmaceutical company
Like many biopharmaceutical companies, our Client was laser-focused on developing new products. As they began to anticipate their IPO, along with the need for public reporting, they turned to RGP for support with improving internal systems and controls.
With our deep expertise in helping healthcare companies navigate the IPO process, RGP helped our biopharmaceutical Client prepare for this change, handling everything from accounting cleanup and financial statement preparation to SOX readiness and equity compensation.
What We Did
- Supported general ledger cleanup, corrected journal entries and updated reconciliations.
- Recommended formal accounting procedures that were implemented by our Client.
- Prepared financial statements, preparation/filing of S-1 and SOX implementation.
- Partnered with the broker to update employee demographics, grants and exercises, and provided transfer agent with exercise details.
- Prepared stock-based compensation expense for SEC reporting.
Impact
- Delivered audit-worthy financial statements going back three years and timely S-1 filing.
- Enabled our Client to demonstrate SOX readiness as a public company.
- Developed new processes and procedures for reporting as a public company, enabling our Client to be ready for trading on Day 1.
- Integrated our Client’s ERP system with Coupa and Host Analytics, backed by NetSuite advisory and system administration support.
Share This
Client
A biopharmaceutical company
Human Insights
Insights from our global thought leaders.
